• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. POD; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. POD; HCG, KRD Back to Search Results
Catalog Number RBYPOD4
Medical Device Problem Codes Physical Resistance/Sticking (4012); Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/15/2022
Type of Reportable Event Malfunction
Event or Problem Description
The patient was undergoing a coil embolization procedure in the gastroduodenal artery (gda) using a pod coil and a non-penumbra microcatheter.During the procedure, the physician advanced a pod coil into the target location and determined the coil was too large for the vessel; therefore, the physician decided to remove the pod coil.However, while retracting the coil, the physician experienced resistance and the pod coil had unintentionally detached inside the microcatheter.Therefore, the microcatheter containing the detached pod coil was removed and the coil was flushed out.The procedure was completed using ruby coils and a new microcatheter.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
This device is available for return.A follow up mdr will be submitted upon completion of the device investigation.
 
Additional Manufacturer Narrative
Evaluation of the returned pod coil confirmed that the embolization coil was detached.Evaluation revealed that the pet lock was separated, and the pull wire was retracted out of the ddt.If this occurs, the embolization will detach from its pusher assembly.Further evaluation of the device revealed kinks on the pusher assembly and offset coil winds on the embolization coil.This damage was likely incidental to the complaint.Penumbra products are visually inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.H3 other text : placeholder.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POD
Common Device Name
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key15380915
Report Number3005168196-2022-00410
Device Sequence Number12217521
Product Code HCG
UDI-Device Identifier00814548013756
UDI-Public814548013756
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K173614
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/07/2022
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/07/2026
Device Catalogue NumberRBYPOD4
Device Lot NumberF81833
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/16/2022
Supplement Date Received by Manufacturer09/23/2022
Initial Report FDA Received Date09/08/2022
Supplement Report FDA Received Date10/07/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/09/2018
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age60 YR
Patient SexMale
Date Report Sent to FDA01/01/2005
-
-